Nonarteritic anterior ischemic optic neuropathy and tobacco smoking

被引:58
作者
Hayreh, Sohan Singh
Jonas, Jost B.
Zimmerman, M. Bridget
机构
[1] Univ Iowa, Coll Med, Dept Ophthalmol, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Med, Dept Visual Sci, Iowa City, IA 52242 USA
[3] Univ Heidelberg, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany
[4] Univ Heidelberg, Med Fac Mannheim, Hosp Eye, Mannheim, Germany
[5] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA
关键词
D O I
10.1016/j.ophtha.2006.07.062
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To evaluate whether tobacco smoking may be a risk factor for development of nonarteritic anterior ischemic optic neuropathy (NA-AION). Design: Cohort study. Participants: Six hundred twenty-four consecutive patients with NA-AION who fulfilled our inclusion criteria. Methods: All patients provided a detailed ocular, medical, and smoking history, and underwent a comprehensive ophthalmic evaluation. For data analysis, patients were divided into current, former, and never smokers. The prevalence for current smoking in the NA-AION patients was compared to the corresponding race-, gender-, age-, and period-matched subgroup of the U.S. population. Main Outcome Measures: Association between NA-AION and tobacco smoking. Results: Of the 624 patients, 369 (59.1 %) were men, and mean (+/- standard deviation) age was 61.0 +/- 12.3 years. Of all the patients, 151 (24.2%) were current smokers, 160 (25.6%) former smokers, and 313 (50.2%) had never smoked. The prevalence of smoking in NA-AION patients was not significantly different from the prevalence in the period-matched U.S. population and the period matched Iowa population. In contrast, the prevalence of diabetes mellitus, ischemic heart disease, arterial hypertension, and cerebrovascular disease in NA-AION patients was significantly higher compared to the prevalence of these chronic conditions in the matched U.S. population (P < 0.0001). There was no significant difference in initial visual acuity (P = 0.97) or the amount of initial visual field loss (P = 0.31) among nonsmokers, former smokers, and current smokers. Current smokers had NA-AION in the first eye at a significantly younger age (57.8 +/- 11.7 years) than former smokers (64.0 +/- 10.2 years; P < 0.0001), and nonsmokers (60.4 +/- 13.5 years; P = 0.032). Comparison of the distribution of the time to develop NA-AION in the fellow eye showed no significant difference among the 3 groups (log-rank test P = 0.186). Conclusions: Our study showed no association between NA-AION and tobacco smoking.
引用
收藏
页码:804 / 809
页数:6
相关论文
共 23 条
[1]   Prothrombotic and atherosclerotic risk factors lack significance in NAION patients harbouring mitochondrial DNA mutations [J].
Abu-Amero, KK ;
Bosley, TM .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2006, 90 (01) :119-120
[2]  
Adams P F, 1999, Vital Health Stat 10, P1
[3]  
[Anonymous], 1985, United States, Vital Health Stat, V10, P1
[4]   Aspirin therapy in nonarteritic anterior ischemic optic neuropathy [J].
Beck, RW ;
Hayreh, SS ;
Podhajsky, PA ;
Tan, ES ;
Moke, PS .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 123 (02) :212-217
[5]  
*CCDP, 1988, BEH RISK FACT SURV S
[6]  
Centers for Disease Control and Prevention, 1995, BEH RISK FACT SURV S
[7]  
CHUNG SM, 1994, OPHTHALMOLOGY, V101, P779
[8]  
Dagenais GR, 2005, EUR J CARDIOV PREV R, V12, P75
[9]  
Hayreh S, 1996, Ophthalmol Clin North Am, V9, P407
[10]   Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management [J].
Hayreh, SS .
EYE, 2004, 18 (11) :1188-1206